Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study

Petru Ifteni,1,2 Andreea Teodorescu,1,2 Marius Alexandru Moga,1 Alina Mihaela Pascu,1 Roxana Steliana Miclaus1,2 1Faculty of Medicine, Transilvania University of Brasov, Brasov, Romania; 2Clinical Hospital of Psychiatry and Neurology Brasov, Brasov, Romania Abstract: Bipolar disorder (BD) is assoc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ifteni P, Teodorescu A, Moga MA, Pascu AM, Miclaus RS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/e15bc056634b47188695294f8eadf75d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e15bc056634b47188695294f8eadf75d
record_format dspace
spelling oai:doaj.org-article:e15bc056634b47188695294f8eadf75d2021-12-02T04:55:31ZSwitching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study1178-2021https://doaj.org/article/e15bc056634b47188695294f8eadf75d2017-01-01T00:00:00Zhttps://www.dovepress.com/switching-bipolar-disorder-patients-treated-with-clozapine-to-another--peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Petru Ifteni,1,2 Andreea Teodorescu,1,2 Marius Alexandru Moga,1 Alina Mihaela Pascu,1 Roxana Steliana Miclaus1,2 1Faculty of Medicine, Transilvania University of Brasov, Brasov, Romania; 2Clinical Hospital of Psychiatry and Neurology Brasov, Brasov, Romania Abstract: Bipolar disorder (BD) is associated with periodic symptom exacerbations, leading to functional impairment, and increased risk of suicide. Although clozapine has never been approved for the treatment of BD, it is occasionally used in severe mania. The aim of the study is to evaluate the risks and benefits of switching clozapine in remitted BD patients. This is an observational, mirror image study of 62 consecutive remitted BD outpatients treated with clozapine. Twenty-five patients were switched to another antipsychotic following a change in a drug reimbursement rule, while 37 continued on clozapine. The mean time in remission was shorter for the switched group (9.2±4 months vs 13±6 months, P=0.018), and the number of patients who relapsed was larger (n=21 vs n=8, P<0.0001). The results suggest that switching from clozapine to another antipsychotic may increase the risk of relapses in remitted patients with BD. Keywords: clozapine, bipolar disorder, relapse, switch, costIfteni PTeodorescu AMoga MAPascu AMMiclaus RSDove Medical Pressarticleclozapinebipolar disorderrelapseswitchcostNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 201-204 (2017)
institution DOAJ
collection DOAJ
language EN
topic clozapine
bipolar disorder
relapse
switch
cost
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle clozapine
bipolar disorder
relapse
switch
cost
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Ifteni P
Teodorescu A
Moga MA
Pascu AM
Miclaus RS
Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
description Petru Ifteni,1,2 Andreea Teodorescu,1,2 Marius Alexandru Moga,1 Alina Mihaela Pascu,1 Roxana Steliana Miclaus1,2 1Faculty of Medicine, Transilvania University of Brasov, Brasov, Romania; 2Clinical Hospital of Psychiatry and Neurology Brasov, Brasov, Romania Abstract: Bipolar disorder (BD) is associated with periodic symptom exacerbations, leading to functional impairment, and increased risk of suicide. Although clozapine has never been approved for the treatment of BD, it is occasionally used in severe mania. The aim of the study is to evaluate the risks and benefits of switching clozapine in remitted BD patients. This is an observational, mirror image study of 62 consecutive remitted BD outpatients treated with clozapine. Twenty-five patients were switched to another antipsychotic following a change in a drug reimbursement rule, while 37 continued on clozapine. The mean time in remission was shorter for the switched group (9.2±4 months vs 13±6 months, P=0.018), and the number of patients who relapsed was larger (n=21 vs n=8, P<0.0001). The results suggest that switching from clozapine to another antipsychotic may increase the risk of relapses in remitted patients with BD. Keywords: clozapine, bipolar disorder, relapse, switch, cost
format article
author Ifteni P
Teodorescu A
Moga MA
Pascu AM
Miclaus RS
author_facet Ifteni P
Teodorescu A
Moga MA
Pascu AM
Miclaus RS
author_sort Ifteni P
title Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
title_short Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
title_full Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
title_fullStr Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
title_full_unstemmed Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
title_sort switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/e15bc056634b47188695294f8eadf75d
work_keys_str_mv AT iftenip switchingbipolardisorderpatientstreatedwithclozapinetoanotherantipsychoticmedicationamirrorimagestudy
AT teodorescua switchingbipolardisorderpatientstreatedwithclozapinetoanotherantipsychoticmedicationamirrorimagestudy
AT mogama switchingbipolardisorderpatientstreatedwithclozapinetoanotherantipsychoticmedicationamirrorimagestudy
AT pascuam switchingbipolardisorderpatientstreatedwithclozapinetoanotherantipsychoticmedicationamirrorimagestudy
AT miclausrs switchingbipolardisorderpatientstreatedwithclozapinetoanotherantipsychoticmedicationamirrorimagestudy
_version_ 1718401041287872512